ixlayer

ixlayer

ixlayer is the only end-to-end, direct-to-patient platform built for biopharma and optimized for patient choice.

Founded 2017

San Francisco, United States 51 employees Series A Total: $75.00M Cloud Infrastructure, Digital Health +2

ixlayer is a cloud-based platform founded in 2018, positioned as the only end-to-end, direct-to-patient platform for the biopharma industry. With a slogan emphasizing its focus on patient choice, ixlayer aims to provide greater operational efficiency, patient access, and improved outcomes for biopharma organizations. The latest reported investment of $75.00M during its Series A round occurred on 11 March 2021. Notable investors in this round include Pear Ventures, Plug and Play Singapore, General Catalyst, Salesforce Ventures, Biospring Partners, MBX Capital, Zeshan Muhammedi, Dara Khosrowshahi, Accenture Ventures, and Anne Wojcicki. ixlayer's platform integrates seamlessly with all systems, enabling biopharma organizations to enhance speed to market, drive engagement and compliance, and improve brand loyalty. The company is headquartered in the United States and operates within the Cloud Infrastructure and Health Care industries. For further details, visit www.ixlayer.com.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$75.00M	10	Pear Ventures, General Catalyst +8	11 Mar 2021
Seed Round	Undisclosed	-		01 Jul 2019
Seed Round	Undisclosed	-		10 May 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$75.00M

Pear Ventures, General Catalyst +8

11 Mar 2021

Seed Round

Undisclosed

01 Jul 2019

Seed Round

Undisclosed

10 May 2018

FAQ About ixlayer

ixlayer is the only end-to-end, direct-to-patient platform built for biopharma and optimized for patient choice.

ixlayer was founded in 2017.

ixlayer is headquartered in San Francisco, United States.

ixlayer operates in Cloud Infrastructure, Digital Health, Health Care and Health and Wellness. Its work centres on digital health, lab testing, diagnostic testing and cloud-based platforms.

ixlayer has approximately 51 employees.

ixlayer has completed 3 funding rounds, raising a total of $75.00M. The latest funding stage is Series A.

Top alternatives and competitors to ixlayer include Okadoc, Ash Wellness, mPulse, Remi Health, CareCloud. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ixlayer and Okadoc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About ixlayer

Funding Rounds & Investors (3)

ixlayer Alternatives & Competitors

FAQ About ixlayer